Clinical Trials Logo

Clinical Trial Summary

In this study, the investigators will explore the effects of repetitive transcranial magnetic stimulation (rTMS) on executive function deficits in high function autism spectrum disorder. Half of the participants will be chosen by chance to receive continuous theta burst stimulation (cTBS) while the other half will be chosen by chance to receive sham stimulation. And finally the sham group individuals also receive cTBS. Based on results from a recent unpublished pilot data, the investigators propose that cTBS treatment will induce a significant improvement in executive function performance compared to sham treatment.


Clinical Trial Description

This study is a randomized, sham controlled study to evaluate the efficacy of cTBS as a treatment for executive function deficits in individuals with autism spectrum disorder between 6 and 16 years of age. The study duration is approximately 1 months, with the cTBS sessions lasting for 4 weeks, 5 times a week, for about 20min each. Several scales will be used to assess for symptom severity and adaptive functioning. The executive function will be evaluated by Behaviour Rating Inventory of Executive Functioning (BRIEF) questionnaire. Cognition will be assessed using functional near - infrared spectroscopy (fNIRS).

This study also involves a type of brain imaging known as magnetic resonance imaging (MRI) at the beginning and at the end of the 4 weeks daily cTBS to better understand the effects of cTBS on brain structure and function. Investigators will measure the size and connections of different parts of the brain to assess brain structure and blood flow. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04237870
Study type Interventional
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact Fei Li, PHD, MD
Phone +86-21-25077461
Email feili@shsmu.edu.cn
Status Recruiting
Phase N/A
Start date January 1, 2019
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04111549 - GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth N/A
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Enrolling by invitation NCT05017779 - A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth N/A
Terminated NCT02416193 - Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D) Phase 2
Recruiting NCT06073717 - Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT). N/A
Completed NCT02613936 - Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury N/A
Recruiting NCT05874791 - Executive Control Training for Adolescents With ADHD: A Randomized Controlled Effectiveness Trial N/A
Recruiting NCT04465708 - HOPS Study: A Conceptual Replication N/A
Active, not recruiting NCT05131659 - Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD N/A
Active, not recruiting NCT04121650 - Executive Function and Symptom Reduction in Youth Receiving Home-based Treatment With Collaborative Problem Solving
Completed NCT04221841 - Executive Functions and Reinforcement Sensitivity in Women With Obsessive Compulsive Symptoms
Completed NCT03490110 - Brain Markers of Improvements in Cognitive Functioning N/A
Completed NCT03285347 - Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease N/A
Completed NCT03073122 - The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease
Completed NCT03958487 - An Executive/Monitoring Treatment Protocol on Everyday Life Activities N/A
Completed NCT02091284 - Bilateral Prefrontal Modulation in Alcoholism N/A
Completed NCT02091167 - Bilateral Prefrontal Modulation in Crack-cocaine Addiction Phase 2
Completed NCT01730261 - Online Emotional Regulation Group Treatment Phase 1
Completed NCT00271596 - Citalopram to Enhance Cognition in HD Phase 2
Active, not recruiting NCT04108728 - Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU ) N/A